The Drug Policy Network South East Europe hosted the side event “Advocacy in Action: Advancing Comprehensive Health and Harm Reduction Services” at the 68th UN Commission on Narcotic Drugs, held from 10 to 14 March 2025 in Vienna.

This side event was organized with the support of Czech Republic, Pompidou Group, UNITE Parliamentarians Network for Global Health, Correlation – European Harm Reduction Network, Eurasian Harm Reduction Association, European Network Of People Who Use Drugs, Re Generation, Villa Maraini, ISGlobal, Fondazione LILA Milano, Asociación Bienestar y Desarrollo, Free Clinic, Spolecnost Podane ruce, and Knowmad Institute.
The session illustrated key advocacy strategies and actions which highlight successful community-led interventions and policy reforms that address barriers such as stigma, legislative hurdles, and funding gaps.
The speakers presented the BOOST Project 2023-2025 (Katrin Schiffer, Correlation), Advocacy Strategy for Comprehensive Health and Harm Reduction Services for People Who Use Drugs in Europe (Ganna Dovbakh, EHRA), Scaling up community involvement for an integrated, responsive and sustainable Harm Reduction (Ligia Parodi, EuroNPUD), and Decriminalization and regulation (Marios Atzemis, DPNSEE). A recorded message from Hon. Halldóra Mogensen, parliamentarian from Iceland, was presented.
Discussion after the presentations included contributions from Czech Republic, Juventas, and Pompidou Group.




The aim of the meeting was to finalize the European Advocacy Strategy, ensuring comprehensive access to HIV, HCV, and TB services for people who use drugs, based on online dialogues and consultations with regional network governing bodies.
The Drug Policy Network South East Europe (DPNSEE) organised two regional online dialogues as part of the
Financing and sustainability of support services pose significant challenges, and the civil sector’s operational space is limited, reflecting a lack of motivation among institutions and decision-makers to enhance the quality of life for these communities. Existing laws related to these communities are problematic, as is the complex and exclusionary nature of accessing healthcare services and treatment programs. Official registers or record-keeping mechanisms are often lacking, and strategies are frequently rewritten without effective implementation.